Haemaccel

Haemaccel is a sterile solution for injection containing polygeline as the active ingredient. It is supplied in a standard concentration (strength not specified) and is administered intravenously as a colloid plasma volume expander. The product is marketed in the European Union and requires a prescription. It is used in clinical settings to restore intravascular volume when blood loss or fluid depletion occurs, providing oncotic pressure comparable to natural plasma proteins.

Haemaccel is indicated for the management of conditions that involve reduced circulating blood volume.

- Acute hypovolemia resulting from hemorrhage or fluid loss - Shock states where rapid plasma volume expansion is required - Surgical blood loss during major operative procedures - Severe burns with extensive fluid shifts - Trauma patients with significant fluid deficits

Adverse reactions to Haemaccel are generally related to its colloid nature and the infusion process.

Common: - Transient hypotension or blood pressure fluctuations - Flushing or feeling of warmth - Mild fever or chills - Nausea or mild gastrointestinal discomfort - Headache or dizziness - Pain or irritation at the injection site

Serious: - Anaphylactic or severe allergic reactions - Marked hypotension leading to cardiovascular compromise - Pulmonary edema due to fluid overload - Hemolysis or red blood cell destruction - Acute renal impairment or failure - Coagulopathy or bleeding disorders

When using Haemaccel, clinicians should consider several safety measures to minimize risk.

- Assess patient volume status and cardiac function before infusion - Use caution in patients with known hypersensitivity to polygeline or gelatin derivatives - Monitor vital signs and urine output throughout administration - Adjust infusion rate in individuals with compromised renal or hepatic function - Avoid rapid bolus administration; prefer controlled infusion - Evaluate for signs of fluid overload, especially in heart failure patients - Pregnancy and lactation status should be confirmed, as safety data are limited

Haemaccel may interact with other agents that affect fluid balance, coagulation, or immune response.

Avoid: - Concurrent use of other colloid solutions that may cause cumulative volume overload - High-dose diuretics that could exacerbate hypovolemia when combined with rapid infusion - Agents known to trigger severe allergic reactions in gelatin-sensitive patients

Use with caution: - Blood products or plasma expanders that alter coagulation parameters - Vasopressors, as rapid volume changes can affect their efficacy - Nephrotoxic drugs, due to potential additive renal stress - Anticoagulants, because plasma expanders may influence bleeding risk